日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Clinical management of cancer after kidney transplantation

肾移植后癌症的临床管理

Hiramitsu, Takahisa; Ienaga, Ayano; Shimamoto, Yuki; Himeno, Tomoki; Hasegawa, Yuki; Futamura, Kenta; Okada, Manabu; Narumi, Shunji; Watarai, Yoshihiko

Impact of treatment strategies incorporating sacubitril/valsartan on achievement of guideline-recommended blood pressure targets and representative safety outcomes

包含沙库巴曲/缬沙坦的治疗策略对达到指南推荐血压目标和典型安全性结果的影响

Katsuya, Tomohiro; Nakatsu, Fumiko; Eguchi, Shunsuke; Nakamura, Yumiko; Matsukawa, Miyuki; Iekushi, Kazuma; Hiramitsu, Shinya

Diagnostic utility of quantitative interferon-gamma release assays in elderly patients with tuberculosis

定量干扰素-γ释放试验在老年结核病患者诊断中的应用价值

Mutoh, Yoshikazu; Minato, Yusuke; Kawamoto, Yuya; Hanai, Shogo; Umemura, Takumi; Suzuki, Hiroko; Nishina, Yuta; Hiramitsu, Kaho; Ichihara, Seiya; Hagimoto, Satoshi; Fukihara, Jun; Sasano, Hajime; Kataoka, Kensuke; Kimura, Tomoki; Doi, Yohei

Calculated Excess-Triglyceride Based on the Friedewald Formula is a Possible Surrogate Marker for the Production of Large Very-Low Density Lipoprotein, A Post-Hoc Analysis of the PROUD48 Study

基于 Friedewald 公式计算的过量甘油三酯可能是大分子极低密度脂蛋白生成的潜在替代标志物——PROUD48 研究的事后分析

Hirano, Tsutomu; Takeda, Yasutaka; Sakuma, Ichiro; Hiramitsu, Shinya; Okada, Mizuho; Ueda, Shinichiro; Sakurai, Masaru

Risk factors for cancer and the importance of screening in adult recipients of living-donor kidney transplant

成人活体肾移植受者罹患癌症的风险因素及筛查的重要性

Hiramitsu, Takahisa; Shimamoto, Yuki; Himeno, Tomoki; Hasegawa, Yuki; Futamura, Kenta; Okada, Manabu; Matsuoka, Yutaka; Goto, Norihiko; Ichimori, Toshihiro; Narumi, Shunji; Kobayashi, Takaaki; Uchida, Kazuharu; Watarai, Yoshihiko

Post-transplantation management of hyperparathyroidism and its association with kidney graft survival and fibrosis

肾移植后甲状旁腺功能亢进的管理及其与肾移植存活率和纤维化的关系

Okada, Manabu; Sato, Tetsuhiko; Himeno, Tomoki; Hasegawa, Yuki; Shimamoto, Yuki; Futamura, Kenta; Hiramitsu, Takahisa; Goto, Norihiko; Narumi, Shunji; Takeda, Asami; Ichimori, Toshihiro; Watarai, Yoshihiko

Rationale and Protocol of the Registry for Contemporary Medical Management of Chronic Heart Failure With Mildly Reduced and Preserved Ejection Fraction - The PARACLETE Study

当代慢性心力衰竭伴轻度降低和射血分数保留的医学管理注册研究的理论基础和方案——PARACLETE 研究

Ueda, Tomoya; Kuwahara, Koichiro; Hiramitsu, Shinya; Onishi, Katsuya; Yumino, Dai; Seno, Ayako; Shiino, Kenji; Nogi, Maki; Isogawa, Masahiro; Kawamoto, Atsuhiko; Kasahara, Masato; Hikoso, Shungo; Saito, Yoshihiko

Impact of Age 70 years or Older on Donors for Living-Donor Kidney Transplantation

70岁及以上年龄对活体肾移植供体的影响

Hiramitsu, Takahisa; Himeno, Tomoki; Hasegawa, Yuki; Futamura, Kenta; Okada, Manabu; Matsuoka, Yutaka; Goto, Norihiko; Ichimori, Toshihiro; Narumi, Shunji; Takeda, Asami; Kobayashi, Takaaki; Uchida, Kazuharu; Watarai, Yoshihiko

Lung cancer after kidney transplantation: a 50-year experience at a single institution

肾移植后肺癌:一家机构50年的经验

Watanabe, Hiroki; Kadomatsu, Yuka; Hakiri, Shuhei; Yoshioka, Hiromu; Hiramitsu, Takahisa; Futamura, Kenta; Okada, Manabu; Goto, Norihiko; Narumi, Shunji; Watarai, Yoshihiko; Chen-Yoshikawa, Toyofumi Fengshi

Phase II Trial of Nivolumab in Metastatic Rare Cancer with dMMR or MSI-H and Relation with Immune Phenotypic Analysis (the ROCK Trial)

纳武利尤单抗治疗伴有 dMMR 或 MSI-H 的转移性罕见癌症的 II 期试验及其与免疫表型分析的关系(ROCK 试验)

Okuma, Hitomi S; Watanabe, Keisuke; Tsuchihashi, Kenji; Machida, Ryunosuke; Sadachi, Ryo; Hirakawa, Akihiro; Ariyama, Hiroshi; Kanai, Masashi; Kamikura, Masahisa; Anjo, Kenta; Hiramitsu, Akari; Sekine, Shigeki; Okita, Natsuko; Mano, Hiroyuki; Nishikawa, Hiroyoshi; Nakamura, Kenichi; Yonemori, Kan